Researchers found that better glucose uptake in the brain compensates for age-related deterioration, leading to longer life. Improved neuronal glucose uptake also coupled with dietary restrictions showed enhanced lifespans.
SourceTokyo Metropolitan University·JournaliScience·DateJan 16, 2021
The NRG Oncology phase II clinical trial determined that the combination of total neoadjuvant therapy with pembrolizumab and chemoradiotherapy is safe for patients with locally-advanced rectal cancer (LARC). However, it may not offer any statistically significant improvement in downstaging of the cancer at the time of surgery.